India Exchange Filings

Suraksha Diagnostic Q2 & H1 FY27 Investor Presentation

Suraksha Diagnostic Ltd reports Q2 FY27 revenue of ₹99.1 crore, up 25.8% YoY, and PAT of ₹15.0 crore

  • EBITDA was ₹36.3 crore, with a 36.7% margin, up 45.5% YoY.
  • PAT margin was 15.1%; no exceptional items were reported.
  • Investor presentation covers unaudited standalone and consolidated Q2 and H1 FY27 results, operating metrics and network expansion.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.